Elisabetta Gatti’s Post

Policy Analyst Digital Health & Tax Advocacy | Johnson and Johnson

3mo Edited

✨ If you know me, you know how much I love talking about AI in health! ;) That's why I am excited to share that Johnson & Johnson has been featured in Artefact and AI for Health's new report: "Revolutionizing Drug Development with AI: The Future of Clinical Trials". Check out the screenshot below for J&J’s perspective, and don’t forget to explore the full report at this link: https://lnkd.in/exNeVvtr This report takes a deep dive into how AI is reshaping clinical trials—making them faster, more efficient, and more inclusive. It was an honor to represent Johnson & Johnson and contribute to such an important discussion alongside industry leaders like Pfizer, Servier, and innovative tech partners like Deemea, Elaia, Google, Inato, and Klineo.

3 Comments

Francesco Carmine Gatti

Tecnico per Trenitalia S.p.A.

1mo

Innovativo.

Sébastien Marguerès

Director - AI for Health by Artefact | Bioengineer

2mo

Thanks for your precious insights!

1 Reaction

Helen Haggart

Director, Government Affairs & Policy, MedTech EMEA at Johnson & Johnson

3mo

Amazing work, Elisabetta!

1 Reaction

See more comments

To view or add a comment, sign in

More Relevant Posts

Tyson Kuehl
5mo Edited
Report this post
Exciting news! 🌟 Dive into the world of AI/ML in clinical trials with our latest white paper authored by my colleague Patrick Brady. Learn about the regulatory expectations, strategic implementation, and benefits of AI/ML across the drug development lifecycle. Keys to Success: 1) Consider the regulatory climate in the markets where you seek approval 2) Design risk-based approaches 3) Develop a set of standards 4) Apply good ML practices 5) Leverage AI/ML strategically in your trial 6) Prepare your project teams for success (don't forget the people component!!) Discover insights on patient recruitment, dose optimization, regulatory compliance, and risk management. Stay ahead in the evolving landscape of drug development by downloading now! #AI #ML #ClinicalTrials #DrugDevelopment #Innovation #IQVIA #RegulatoryAffairs #BigPharma Eliza Silvester, Matthew Smith, Matt Doyle, Nick Mageras, Carmen Sivakumaren, PhD Abir Yamak, Ph.D. Eric E. Bayir, MSc, MBA, Gonzalo Lemus, Charles Vizzini, Greg Plante, Aziz Mallik, Elyse Muñoz, PhD, Leah Magid Herbert Valerie Eng John DeMarrais Ian Fisher Reid D'Amico, Ph.D. Rob Glik Erin Gerardo Rounak Baid Thomas J. Franco Terry Shea Luke Greenwalt Michel Denarie Jun G. Adrian McKemey Paul Villa Kelley Coalier, MS, MBA Gopa Radhakrishnan, MPH Daniel Feld, MBA, MPH Angela Donato James Noll Aakansha Nangarlia, PhD Amritha J. Yash Dave, Elizabeth Powers, Patrick Dunn, Bill Jensen

Artificial Intelligence in Drug Development

iqvia.com
Like Comment
To view or add a comment, sign in
ICON plc

576,250 followers
10mo
Report this post
From data overload to data empowerment – learn how ICON is using the transformative power of AI to manage and interpret vast amounts of clinical trial data to improve site selection. Read the whitepaper. https://ow.ly/ZlBn50R3Vkx #DataEmpowerment #AIInnovation #ClinicalInsights

Using AI in site ID and selection | Download now

iconplc.com
Like Comment
To view or add a comment, sign in
AMG World

2,578 followers
3mo
Report this post
We are excited to announce that Piotr Maślak, Director of Data Intelligence at AstraZeneca, will present his thoughts on the impact of metrics strategy on #ClinicalTrial acceleration at the Disruptive Technology for Clinical Trials Summit Europe in London, UK (28 January 2025). Gain valuable insights from industry leaders like Piotr to optimise your clinical trials by registering online today: https://lnkd.in/eZFC_4QT #DisruptiveCTEurope #DataAnalysis #DisruptiveTechnology #AI #DataCollective #Pharma #DigitalTransformation
Charmaine C.

Conference producer at AMG World
3mo

When researching for the Disruptive Technology for Clinical Trials Summit Europe (28 January 2025, London, UK), I thoroughly enjoyed my conversation with Piotr Maślak where we discussed #datastrategy in clinical trials. Following this, I’m looking forward to his presentation on the impact of metrics strategy on clinical trial acceleration. Piotr is passionate about turning #data into meaningful business value and he is highly experienced in designing and executing data-driven strategies that allow for more informed decision-making. He has experience spanning across #datascience, #AI implementation and product management to name a few, so he is sure to bring great value to the event. Find out more and secure your spot today https://lnkd.in/ebFQWQsN #DisruptiveCTEurope #DataAnalysis #DisruptiveTechnology #AI #DataCollective #Pharma #DigitalTransformation
Like Comment
To view or add a comment, sign in
Bob Hayes, PhD

Data Science, Customer Experience/Success, Machine Learning
3mo
Report this post
When life sciences met #artificialintelligence 79% of respondents are actively using or planning to use AI to “drive faster, more efficient drug discovery and clinical trials.” https://buff.ly/4hYGRus #healthcare

When life sciences met artificial intelligence

aiin.healthcare
Like Comment
To view or add a comment, sign in
Bob Hayes, PhD

Data Science, Customer Experience/Success, Machine Learning
3mo
Report this post
When life sciences met #artificialintelligence 79% of respondents are actively using or planning to use AI to “drive faster, more efficient drug discovery and clinical trials.” https://lnkd.in/gVTRdA37 #healthcare

When life sciences met artificial intelligence

aiin.healthcare
Like Comment
To view or add a comment, sign in
Bob Hayes, PhD

Data Science, Customer Experience/Success, Machine Learning
3mo
Report this post
When life sciences met #artificialintelligence 79% of respondents are actively using or planning to use AI to “drive faster, more efficient drug discovery and clinical trials.” https://lnkd.in/gVTRdA37 #healthcare

When life sciences met artificial intelligence

aiin.healthcare
Like Comment
To view or add a comment, sign in
Tim Martin

Artificial Intelligence / Natural Language Processing / Enterprise Software
1mo
Report this post
We are proud to be working with Eli Lilly and Novo Nordisk to drive industry awareness around maximizing efficiencies in Medical Writing using AI.
Yseop

11,361 followers
1mo

Generative AI is reshaping clinical documentation and regulatory submissions, offering faster, more efficient processes. However, its true success lies in addressing critical challenges: data readiness, optimizing content ecosystems, and eliminating inefficiencies in CSR creation. vanessa de langsdorff of Yseop recently collaborated with John April of Eli Lilly and Company and Inger Ødum Nielsen of Novo Nordisk to publish an article in Applied Clinical Trials Magazine, exploring how organizations are overcoming these challenges and maximizing the return on GenAI investments. 📖 Read the full piece here: https://lnkd.in/eD8i4QiG #GenerativeAI #MedicalWriting #RegulatoryAffairs
1 Comment
Like Comment
To view or add a comment, sign in
ICON plc

576,250 followers
9mo
Report this post
Our latest whitepaper examines the role of AI in driving more efficient and effective site selection and promoting diversity and equity in clinical trials. Read more: https://ow.ly/ASx150R3VY0 #InclusiveHealthcare #PatientRepresentation #AIInclusion

Using AI in site ID and selection | Download now

iconplc.com

1 Comment
Like Comment
To view or add a comment, sign in
ICON plc

576,250 followers
10mo
Report this post
How can AI enhance patient diversity in clinical trials? Find out in our latest whitepaper, where we explore the role of human-enabled AI in promoting inclusivity and representation. Download your copy today. https://ow.ly/w2WJ50R3V6m #DiversityInClinicalTrials #PatientRecruitment #AIInclusion

Using AI in site ID and selection | Read the whitepaper

iconplc.com
Like Comment
To view or add a comment, sign in
eMQT

605 followers
9mo Edited
Report this post
Our revolutionary Alpha4Pharma solution harnesses the transformative power of Artificial Intelligence to supercharge efficiency in the clinical development landscape🌟By addressing key challenges and unlocking economic value across multiple dimensions, Alpha4Pharma is redefining the future of clinical trials. With the implementation of Generative AI, we're witnessing remarkable outcomes: 🌐Up to 50% cost reductions achieved through the streamlining of clinical trial processes and the auto-drafting of trial documents. 🌐Acceleration of trial timelines by 12 months or more, ensuring quicker access to life-saving treatments for patients in need. 🌐A substantial increase in Net Present Value (NPV) of at least 20%, driven by improved interactions with health authorities, enhanced quality control measures, and optimised signal management. These ground-breaking advancements are not just reshaping the clinical trial landscape; they're paving the way for a more efficient, cost-effective, and patient-centric approach to drug development. Learn more about how Alpha4Pharma is revolutionising the industry: https://buff.ly/49u8uHr #Alpha4Pharma #GenAI #ClinicalTrials #Innovation 🚀💡 Shalom Lloyd MBE Tina Barton Hannah White Emily Moore Nancy Meyerson-Hess Jean Edwards Consulting
Like Comment
To view or add a comment, sign in

1,253 followers

23 Posts

View Profile Follow

Elisabetta Gatti’s Post

More Relevant Posts

Explore topics